Skip to Content

Drug Interactions between lidocaine / oxytetracycline and sarilumab

This report displays the potential drug interactions for the following 2 drugs:

  • lidocaine/oxytetracycline
  • sarilumab

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

lidocaine sarilumab

Applies to: lidocaine / oxytetracycline and sarilumab

Sarilumab may decrease the blood levels and effects of lidocaine. You may need a dose adjustment if you have been receiving lidocaine and are starting treatment with sarilumab. Likewise, if you have been receiving both medications, the dose of lidocaine may need to be adjusted when sarilumab is discontinued. Contact your doctor if your condition changes or you experience increased side effects. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

oxytetracycline food

Applies to: lidocaine / oxytetracycline

Do not take iron supplements, multivitamins, calcium supplements, antacids, or laxatives within 2 hours before or after taking oxytetracycline. These products can make oxytetracycline less effective in treating your infection. Do not take oxytetracycline with milk or other dairy products, unless your doctor has told you to. Dairy products can make it harder for your body to absorb the medication.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide